Scientific Publications
Title
Discovery and Characterization of XY101, a Potent, Selective, and Orally Bioavailable RORγ Inverse Agonist for Treatment of Castration-Resistant Prostate Cancer
First author
Yan Zhang,Xishan Wu,Xiaoqian Xue,Chenchang Li,Junjian Wang,Rui Wang,cheng Zhang,Chao Wang,Yudan Shi,Lingjiao Zou,Qiu Li,Zenghong Huang,Xiaojuan Hao,Kerry M. Loomes,Donghai Wu,Hongwu Chen,Jinxin Xu,Yong Xu
Contact the author
Yong Xu
Page number
4716-4730
Issue
9
PubYear
2019 May;
Subject category
62
Publication name
Journal of Medicinal Chemistry